Fine-Mapping the Genetic Association of the Major Histocompatibility Complex in Multiple Sclerosis: HLA and Non-HLA Effects

Regression shrinkage and selection via the lasso

Tibshirani, R. (1996) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1996.tb02080.x · Cited by 51,482

UCSF Chimera—A visualization system for exploratory research and analysis

Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20084 · Cited by 45,882

PLINK: a tool set for whole-genome association and population-based linkage analyses.

Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., Maller, J., Sklar, P., de Bakker, P. I. W., Daly, M. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519795 · Cited by 34,089

Regularization and Variable Selection Via the Elastic Net

Zou, H., & Hastie, T. (2005) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.1467-9868.2005.00503.x · Cited by 20,957

An integrated encyclopedia of DNA elements in the human genome

The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072

Least angle regression

Efron, B., Hastie, T., Johnstone, I., & Tibshirani, R. (2004) · The Annals of Statistics · doi:10.1214/009053604000000067 · Cited by 9,357

A note on a general definition of the coefficient of determination

NAGELKERKE, N. J. D. (1991) · Biometrika · doi:10.1093/biomet/78.3.691 · Cited by 5,927

Regression Shrinkage and Selection via The Lasso: A Retrospective

Tibshirani, R. J. (2011) · Journal of the Royal Statistical Society Series B (Statistical Methodology) · doi:10.1111/j.1467-9868.2011.00771.x · Cited by 3,601

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

The International Multiple Sclerosis Genetics Consortium & The Wellcome Trust Case Control Consortium 2 (2011) · Nature · doi:10.1038/nature10251 · Cited by 2,697

ChromHMM: automating chromatin-state discovery and characterization

Ernst, J., & Kellis, M. (2012) · Nature Methods · doi:10.1038/nmeth.1906 · Cited by 2,457

Immune system regulation and role of the human leukocyte antigen in posttraumatic stress disorder

Katrinli, Ş., & Smith, A. K. (2021) · Neurobiology of Stress · doi:10.1016/j.ynstr.2021.100366 · Cited by 27

Analysis of genes, pathways and networks involved in disease severity and age at onset in primary-progressive multiple sclerosis

Giacalone, G., Clarelli, F., Osiceanu, A. M., Guaschino, C., Brambilla, P., Sorosina, M., Liberatore, G., Zauli, A., Esposito, F., Rodegher, M., et al. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458514564590 · Cited by 27

A genetic variant associated with multiple sclerosis inversely affects the expression of CD58 and microRNA-548ac from the same gene

Hecker, M., Boxberger, N., Illner, N., Fitzner, B., Schröder, I., Winkelmann, A., Dudešek, A., Meister, S., Koczan, D., Lorenz, P., et al. (2019) · PLoS Genetics · doi:10.1371/journal.pgen.1007961 · Cited by 26

Macrophages and HLA-Class II Alleles in Multiple Sclerosis: Insights in Therapeutic Dynamics

Prapas, P., & Anagnostouli, M. C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137354 · Cited by 26

Deconstruction of HLA-DRB1*04:01:01 and HLA-DRB1*15:01:01 class II haplotypes using next-generation sequencing in European-Americans with multiple sclerosis

Creary, L. E., Mallempati, K. C., Gangavarapu, S., Caillier, S. J., Oksenberg, J. R., & Fernández-Viña, M. (2018) · Multiple Sclerosis Journal · doi:10.1177/1352458518770019 · Cited by 24

DRB1–environment interactions in multiple sclerosis etiology: results from two Swedish case–control studies

Hedström, A. K., Hillert, J. A., Brenner, N., Butt, J., Waterboer, T., Stridh, P., Kockum, I. S., Olsson, T. P., & Alfredsson, L. S. (2021) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-325676 · Cited by 29

Haplotype-based approach to known MS-associated regions increases the amount of explained risk

Khankhanian, P., Gourraud, P., Lizée, A., & Goodin, D. S. (2015) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2015-103071 · Cited by 22

SUMMIT (Serially Unified Multicenter Multiple Sclerosis Investigation): creating a repository of deeply phenotyped contemporary multiple sclerosis cohorts

Bove, R. M., Chitnis, T., Cree, B., Tintoré, M., Naegelin, Y., Uitdehaag, B. M. J., Kappos, L., Khoury, S. J., Montalbán, X., Hauser, S. L., et al. (2017) · Multiple Sclerosis Journal · doi:10.1177/1352458517726657 · Cited by 23

Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis Pathogenesis

Tschochner, M., Leary, S., Cooper, D., Strautins, K., Chopra, A., Clark, H., Choo, L., Dunn, D., JAMES, I. R., Carroll, W. M., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147567 · Cited by 22

Involvement of Genetic Factors in Multiple Sclerosis

Ferrè, L., Filippi, M., & Esposito, F. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.612953 · Cited by 24

DNA Methylation Signatures of Multiple Sclerosis Occur Independently of Known Genetic Risk and Are Primarily Attributed to B Cells and Monocytes

Xavier, A., Maltby, V. E., Ewing, E., Campagna, M. P., Burnard, S. M., Tegner, J. N., Slee, M., Butzkueven, H., Kockum, I. S., Kular, L., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612576 · Cited by 25

The Short and Long-Term Effects of Pregnancy on Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis

McCombe, P. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7120494 · Cited by 21

Investigating the Causal Effect of Brain Expression of CCL2, NFKB1, MAPK14, TNFRSF1A, CXCL10 Genes on Multiple Sclerosis: A Two-Sample Mendelian Randomization Approach

Fazia, T., Nova, A., Gentilini, D., Beecham, A. H., Piras, M., Saddi, V., Ticca, A., Bitti, P., McCauley, J. L., Berzuini, C., et al. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00397 · Cited by 22

EBNA-1 titer gradient in families with multiple sclerosis indicates a genetic contribution

Mescheriakova, J. Y., van Nierop, G. P., van der Eijk, A. A., Kreft, K. L., & Hintzen, R. Q. (2020) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000872 · Cited by 22

Genomic imprinting: A missing piece of the Multiple Sclerosis puzzle?

Ruhrmann, S., Stridh, P., Kular, L., & Jagodic, M. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.05.010 · Cited by 22

Sequence similarity between SARS-CoV-2 nucleocapsid and multiple sclerosis-associated proteins provides insight into viral neuropathogenesis following infection

Lake, C. M., & Breen, J. J. (2023) · Scientific Reports · doi:10.1038/s41598-022-27348-8 · Cited by 21

Evidence of epistasis in regions of long-range linkage disequilibrium across five complex diseases in the UK Biobank and eMERGE datasets

Singhal, P., Veturi, Y., DUDEK, S. M., Lucas, A., Frase, A., Steen, K. V., Schrodi, S. J., Fasel, D. A., Weng, C., Pendergrass, R. K., et al. (2023) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2023.03.007 · Cited by 20

The Use of Compounds Derived from Cannabis sativa in the Treatment of Epilepsy, Painful Conditions, and Neuropsychiatric and Neurodegenerative Disorders

Stasiłowicz-Krzemień, A., Nogalska, W., Maszewska, Z., Maleszka, M., Dobroń, M., Szary, A., Kępa, A., Żarowski, M., Hojan, K., Łukowicz, M., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115749 · Cited by 28

DQB1*06:02-Associated Pathogenic Anti-Myelin Autoimmunity in Multiple Sclerosis-Like Disease: Potential Function of DQB1*06:02 as a Disease-Predisposing Allele

Kaushansky, N., & ben-Nun, A. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00280 · Cited by 24

Feasibility study for remote assessment of cognitive function in multiple sclerosis

Barcellos, L. F. (2016) · Journal of Neurology and Neuromedicine · doi:10.29245/2572.942x/2016/8.1084 · Cited by 21

Linkage analysis and whole exome sequencing identify a novel candidate gene in a Dutch multiple sclerosis family

Mescheriakova, J. Y., Verkerk, A. J. M. H., Amin, N., Uitterlinden, A. G., van Duijn, C. M., & Hintzen, R. Q. (2018) · Multiple Sclerosis Journal · doi:10.1177/1352458518777202 · Cited by 21

Polygenic Multiple Sclerosis Risk and Population‐Based Childhood Brain Imaging

de Mol, C. L., Jansen, P. R., Muetzel, R. L., Knol, M. J., Adams, H. H. H., Jaddoe, V. W. V., Vernooij, M. W., Hintzen, R. Q., White, T. J. H., & Neuteboom, R. F. (2020) · Annals of Neurology · doi:10.1002/ana.25717 · Cited by 21

The influence of HLA genetic variation on plasma protein expression

Krishna, C., Chiou, J., Sakaue, S., Kang, J. B., Christensen, S. M., Lee, I., Aksit, M. A., Kim, H. I., von Schack, D., Raychaudhuri, S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50583-8 · Cited by 22

A non-synonymous single-nucleotide polymorphism associated with multiple sclerosis risk affects the EVI5 interactome

Didonna, A., Isobe, N., Caillier, S. J., Li, K. H., Burlingame, A. L., Hauser, S. L., Baranzini, S. E., Patsopoulos, N. A., & Oksenberg, J. R. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv412 · Cited by 20

High resolution HLA analysis reveals independent class I haplotypes and amino-acid motifs protective for multiple sclerosis

Mack, S. J., Udell, J. B. M., Cohen, F., Osoegawa, K., Hawbecker, S. K., Noonan, D. A., Ladner, M. B., Goodridge, D., Trachtenberg, E., Oksenberg, J. R., et al. (2018) · Genes and Immunity · doi:10.1038/s41435-017-0006-8 · Cited by 20

Ancestral risk modification for multiple sclerosis susceptibility detected across the Major Histocompatibility Complex in a multi-ethnic population

Beecham, A. H., Amezcua, L., Chinea, A. R., Manrique, C. P., Gomez, L., Martínez, A., Beecham, G. W., Patsopoulos, N. A., Chitnis, T., Weiner, H. L., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0279132 · Cited by 19

Automated machine learning for genome wide association studies

Lakiotaki, K., Papadovasilakis, Z., Lagani, V., Fafalios, S., Charonyktakis, P., Tsagris, M., & Tsamardinos, I. (2023) · Bioinformatics · doi:10.1093/bioinformatics/btad545 · Cited by 19

New insights into the genetic component of non-infectious uveitis through an Immunochip strategy

Márquez, A., Cordero‐Coma, M., Martín‐Villa, J. M., Gorroño-Echebarría, M. B., Blanco, R., Díaz‐Valle, D., del Rio, M. J., Blanco, A., Olea, J. L., Cordero, Y., et al. (2016) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2016-104144 · Cited by 17

Multiple Sclerosis: Basic and Clinical

Buzzard, K. A., Chan, W. H., Kilpatrick, T. J., & Murray, S. S. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-57193-5_8 · Cited by 26

Familial multiple sclerosis in Greece: Distinct clinical and imaging characteristics in comparison with the sporadic disease

Katsavos, S., Artemiadis, A., Davaki, P., Stamboulis, E., Kilindireas, K., & Anagnostouli, M. C. (2018) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2018.08.021 · Cited by 19

Multiple sclerosis and human leukocyte antigen genotypes: Focus on the Middle East and North Africa region

Maghbooli, Z., Sahraian, M. A., & Moghadasi, A. N. (2020) · Multiple Sclerosis Journal - Experimental Translational and Clinical · doi:10.1177/2055217319881775 · Cited by 18

Treatment- and population-specific genetic risk factors for anti-drug antibodies against interferon-beta: a GWAS

Andlauer, T. F. M., Link, J., Martin, D., Ryner, M. L., Hermanrud, C. E., Grummel, V., Auer, M., Hegen, H., Aly, L., Gasperi, C., et al. (2020) · BMC Medicine · doi:10.1186/s12916-020-01769-6 · Cited by 18

Cross-Trait Mendelian Randomization Study to Investigate Whether Migraine Is a Risk Factor for Multiple Sclerosis

Horton, M. K., Robinson, S. C., Shao, X., Quach, H., Quach, D. L., Choudhary, V., Bellesis, K. H., Dorin, P., Mei, J., Chinn, T., et al. (2023) · Neurology · doi:10.1212/wnl.0000000000206791 · Cited by 17

Alemtuzumab for the treatment of multiple sclerosis

Willis, M., & Robertson, N. (2015) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s80112 · Cited by 17

The Role of HLA in MS Susceptibility and Phenotype

Greer, J. M. (2014) · Current topics in behavioral neurosciences · doi:10.1007/7854_2014_357 · Cited by 17

EPIGENETIC MECHANISMS IN MULTIPLE SCLEROSIS.

Gacias, M., & Casaccia, P. (2014) · PubMed · Cited by 17

The Role of Autoimmunity-Related Gene CLEC16A in the B Cell Receptor–Mediated HLA Class II Pathway

Rijvers, L., Melief, M., van Langelaar, J., de Vries, R. M. V. D. V., Wierenga‐Wolf, A. F., Koetzier, S. C., Priatel, J. J., Jorritsma, T., van Ham, S. M., Hintzen, R. Q., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901409 · Cited by 17

Immunodietica: interrogating the role of diet in autoimmune disease

Gershteyn, I. M., Burov, A. A., Miao, B. Y., Morais, V. H., & Ferreira, L. M. R. (2020) · International Immunology · doi:10.1093/intimm/dxaa054 · Cited by 16

HLA high-resolution typing by next-generation sequencing in Pandemrix-induced narcolepsy

Lind, A., Akel, O., Wallenius, M., Ramelius, A., Maziarz, M., Zhao, L. P., Geraghty, D. E., Palm, L., Lernmark, Å., & Larsson, H. E. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222882 · Cited by 15

Genetic susceptibility to multiple sclerosis in African Americans

Goodin, D. S., Oksenberg, J. R., Douillard, V., Gourraud, P., & Vince, N. (2021) · PLoS ONE · doi:10.1371/journal.pone.0254945 · Cited by 15

Investigation of TSPO Variants in Schizophrenia and Antipsychotic Treatment Outcomes

Pouget, J. G., Gonçalves, V. F., Nurmi, E. L., Laughlin, C., Mallya, K. S., McCracken, J. T., Aman, M. G., McDougle, C. J., Scahill, L. D., Misener, V. L., et al. (2015) · Pharmacogenomics · doi:10.2217/pgs.14.158 · Cited by 16

Gene–environment interactions increase the risk of pediatric-onset multiple sclerosis associated with ozone pollution

Ziaei, A., Lavery, A. M., Shao, X., Adams, C., Casper, T. C., ROSE, J. W., Candee, M. S., Weinstock‐Guttman, B., Aaen, G. S., Harris, Y., et al. (2022) · Multiple Sclerosis Journal · doi:10.1177/13524585211069926 · Cited by 14

Epstein–Barr virus and genetic risk variants as determinants of T-bet+ B cell-driven autoimmune diseases

Bogers, L., Kuiper, K. L., Smolders, J., Rip, J., & van Luijn, M. M. (2023) · Immunology Letters · doi:10.1016/j.imlet.2023.07.006 · Cited by 14

Monoclonal Antibodies as Therapeutic Agents in Autoimmune and Neurodegenerative Diseases of the Central Nervous System: Current Evidence on Molecular Mechanisms and Future Directions

Skarlis, C., Angelopoulou, E., Rentzos, M., Papageorgiou, S. G., & Anagnostouli, M. C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199398 · Cited by 15

Local Joint Testing Improves Power and Identifies Hidden Heritability in Association Studies

Brown, B. C., Price, A. L., Patsopoulos, N. A., & Zaitlen, N. (2016) · Genetics · doi:10.1534/genetics.116.188292 · Cited by 12

Two genetic variants explain the association of European ancestry with multiple sclerosis risk in African-Americans

Nakatsuka, N. J., Patterson, N. J., Patsopoulos, N. A., Altemose, N., Tandon, A., Beecham, A. H., McCauley, J. L., Isobe, N., Hauser, S. L., Jager, P. L. D., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-74035-7 · Cited by 13

High Resolution Haplotype Analyses of Classical HLA Genes in Families With Multiple Sclerosis Highlights the Role of HLA-DP Alleles in Disease Susceptibility

Osoegawa, K., Creary, L. E., Montero-Martín, G., Mallempati, K. C., Gangavarapu, S., Caillier, S. J., Santaniello, A., Isobe, N., Hollenbach, J. A., Hauser, S. L., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.644838 · Cited by 13

HLA class II peptide-binding-region analysis reveals funneling of polymorphism in action

Sarri, C. A., Giannoulis, T., Moutou, K. A., & Mamuris, Z. (2021) · Immunology Letters · doi:10.1016/j.imlet.2021.07.005 · Cited by 13

Genetic susceptibility to multiple sclerosis: Brain structure and cognitive function in the general population

Ikram, M. A., Vernooij, M. W., Roshchupkin, G. V., Albert Hofman, D., van Duijn, C. M., Uitterlinden, A. G., Niessen, W. J., Hintzen, R. Q., & Adams, H. H. H. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458516682104 · Cited by 13

Genetic susceptibility to multiple sclerosis: interactions between conserved extended haplotypes of the MHC and other susceptibility regions

Goodin, D. S., Khankhanian, P., Gourraud, P., & Vince, N. (2021) · BMC Medical Genomics · doi:10.1186/s12920-021-01018-6 · Cited by 14

Indications de l’autogreffe dans la sclérose en plaques : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC) en lien avec la Société francophone de la sclérose en plaques

Zéphir, H., Puyade, M., Guéguen, A., Michel, L., Terriou, L., Dive, D., Laureys, G., Mathey, G., Labauge, P. M., Marjanovic, Z., et al. (2018) · Bulletin du Cancer · doi:10.1016/j.bulcan.2018.11.002 · Cited by 12

Contribution of common risk variants to multiple sclerosis in Orkney and Shetland

Barnes, C. L. K., Hayward, C., Porteous, D. J., Campbell, H. J., Joshi, P. K., & Wilson, J. F. (2021) · European Journal of Human Genetics · doi:10.1038/s41431-021-00914-w · Cited by 12

Genetic contribution to multiple sclerosis risk among Ashkenazi Jews

Khankhanian, P., Matsushita, T., Madireddy, L., Lizée, A., Din, L., Moré, J. M., Gourraud, P., Hauser, S. L., Baranzini, S. E., & Oksenberg, J. R. (2015) · BMC Medical Genetics · doi:10.1186/s12881-015-0201-2 · Cited by 12

HLA-DRB1 allele impact on pediatric multiple sclerosis in a Hellenic cohort

Gontika, M. P., Skarlis, C., Artemiadis, A., Pons, R. M., Mastroyianni, S. D., Vartzelis, G., Theodorou, V., Kilindireas, K., Stefanis, L., Dalakas, M. C., et al. (2020) · Multiple Sclerosis Journal - Experimental Translational and Clinical · doi:10.1177/2055217320908046 · Cited by 12

High-dose vitamin B supplementation for persistent visual deficit in multiple sclerosis: a pilot study

Mallone, F., Lucchino, L., Franzone, F., Marenco, M., Carlesimo, S. C., & Moramarco, A. (2020) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2020.03031 · Cited by 12

Therapeutic interference with leukocyte recirculation in multiple sclerosis

Sellebjerg, F. T., & Sørensen, P. S. (2015) · European Journal of Neurology · doi:10.1111/ene.12668 · Cited by 11

Implication of genetic variants in primary microRNA processing sites in the risk of multiple sclerosis

Hecker, M., Fitzner, B., Putscher, E., Schwartz, M., Winkelmann, A., Meister, S., Dudešek, A., Koczan, D., Lorenz, P., Boxberger, N., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104052 · Cited by 12

Immune Responses to Non-Tumor Antigens in the Central Nervous System

Huber, A. K., Duncker, P. C., & Irani, D. N. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00328 · Cited by 11

Genome-wide identification of cis DNA methylation quantitative trait loci in three Southeast Asian Populations

Kassam, I., Tan, S., Gan, F. F., Saw, W., Tan, L. W.-L., Moong, D. K. N., Soong, R. C. T., Teo, Y., & Loh, M. C. S. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab038 · Cited by 11

HLA-DPB1*03 as Risk Allele and HLA-DPB1*04 as Protective Allele for Both Early- and Adult-Onset Multiple Sclerosis in a Hellenic Cohort

Anagnostouli, M. C., Artemiadis, A., Gontika, M. P., Skarlis, C., Markoglou, N., Katsavos, S., Kilindireas, K., Doxiadis, I. I. N., & Stefanis, L. (2020) · Brain Sciences · doi:10.3390/brainsci10060374 · Cited by 11

Genetic Association in the HLA Region

Moutsianas, L., & Gutierrez‐Achury, J. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7868-7_8 · Cited by 11

A Role for the Non-Receptor Tyrosine Kinase Abl2/Arg in Experimental Neuroinflammation

Jacobsen, F. A., Scherer, A. N., Mouritsen, J., Bragadóttir, H., Bäckström, B. T., Sardar, S., Holmberg, D., Koleske, A. J., & Andersson, Å. (2018) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-018-9783-8 · Cited by 11

HLA-DRB1 differences in allelic distribution between familial and sporadic multiple sclerosis in a Hellenic cohort

Katsavos, S., Artemiadis, A., Gontika, M. P., Skarlis, C., Markoglou, N., Davaki, P., Stamboulis, E., Kilindireas, K., Stefanis, L., & Anagnostouli, M. C. (2019) · Postgraduate Medicine · doi:10.1080/00325481.2019.1655382 · Cited by 10

Two susceptible HLA-DRB1 alleles for multiple sclerosis differentially regulate anti-JC virus antibody serostatus along with fingolimod

Watanabe, M., Nakamura, Y., Isobe, N., Tanaka, M., Sakoda, A., Hayashi, F., Kawano, Y., Yamasaki, R., Matsushita, T., & Kira, J. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01865-7 · Cited by 10

Fine mapping the MHC region identified rs4997052 as a new variant associated with nonobstructive azoospermia in Han Chinese males

Huang, M., Zhu, M., Jiang, T., Wang, Y., Wang, C., Jin, G., Guo, X., Sha, J., Dai, J., Wang, X., et al. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.08.052 · Cited by 10

Gene Expression in Spontaneous Experimental Autoimmune Encephalomyelitis Is Linked to Human Multiple Sclerosis Risk Genes

Faber, H., Kurtoic, D., Krishnamoorthy, G., Weber, P. C., Pütz, B., Müller‐Myhsok, B., Weber, F., & Andlauer, T. F. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02165 · Cited by 12

Rare and low-frequency coding genetic variants contribute to pediatric-onset multiple sclerosis

Horton, M. K., Shim, J. E., Wallace, A. D., Graves, J. S., Aaen, G. S., Greenberg, B. M., Mar, S., Wheeler, Y., Weinstock‐Guttman, B., Waldman, A. T., et al. (2023) · Multiple Sclerosis Journal · doi:10.1177/13524585221150736 · Cited by 10

Annotation of functional variation within non-MHC MS susceptibility loci through bioinformatics analysis

Briggs, F. B. S., Leung, L., & Barcellos, L. F. (2014) · Genes and Immunity · doi:10.1038/gene.2014.37 · Cited by 9

Expression and clinical significance of IL7R, NFATc2, and RNF213 in familial and sporadic multiple sclerosis

Imani, S. Z. H., Hojati, Z., Khalilian, S., Dehghanian, F., Kheirollahi, M., Khorrami, M., Shaygannejad, V., & Mirmosayyeb, O. (2021) · Scientific Reports · doi:10.1038/s41598-021-98691-5 · Cited by 9

Association of HLA-B Gene Polymorphisms with Type 2 Diabetes in Pashtun Ethnic Population of Khyber Pakhtunkhwa, Pakistan

Jan, A., Saeed, M., Afridi, M. H., Khuda, F., Shabbir, M., Khan, H., Ali, S., Hassan, M., Ullah, S., Akbar, R., et al. (2021) · Journal of Diabetes Research · doi:10.1155/2021/6669731 · Cited by 10

Identifying novel proteins for migraine by integrating proteomes from blood and CSF with genome‐wide association data

Niu, P., Zhang, R., Zhang, C., Li, S., & Li, Y. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14817 · Cited by 10

Rubella virus seropositivity after infection or vaccination as a risk factor for multiple sclerosis

Ingvarsson, J., Grut, V., Biström, M., Berg, L. P., Stridh, P., Huang, J., Hillert, J. A., Alfredsson, L. S., Kockum, I. S., Olsson, T. P., et al. (2024) · European Journal of Neurology · doi:10.1111/ene.16387 · Cited by 7

Burden of genetic risk variants in multiple sclerosis families in the Netherlands

Mescheriakova, J. Y., Broer, L., Wahedi, S., Uitterlinden, A. G., van Duijn, C. M., & Hintzen, R. Q. (2016) · Multiple Sclerosis Journal - Experimental Translational and Clinical · doi:10.1177/2055217316648721 · Cited by 9

The immunogenetics of multiple sclerosis. The frequency of HLA-alleles class 1 and 2 is lower in Southern Brazil than in the European population

Werneck, L. C., Lorenzoni, P. J., Arndt, R. C., Kay, C. S. K., & Scola, R. H. (2016) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x20160100 · Cited by 8

Computational modeling of brain pathologies: the case of multiple sclerosis

Pappalardo, F., Rajput, A.-M., & Motta, S. (2016) · Briefings in Bioinformatics · doi:10.1093/bib/bbw123 · Cited by 9

Distinct HLA class I and II genotypes and haplotypes are associated with multiple sclerosis in Bahrain

Al-Nashmi, M. E., Taha, S., Salem, A. H., Alsharoqi, I. A., & Bakhiet, M. (2018) · Biomedical Reports · doi:10.3892/br.2018.1164 · Cited by 8

Accurate multi-population imputation of MICA, MICB, HLA-E, HLA-F and HLA-G alleles from genome SNP data

Tammi, S., Koskela, S., Biobank, B. S., Hyvärinen, K., Partanen, J., & Ritari, J. (2024) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1011718 · Cited by 8

Shared genetic architecture and causal relationship between sleep behaviors and lifespan

Wu, Y., Zhang, C., Liu, X., Wang, L., Li, M., Li, Y., & Xiao, X. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02826-x · Cited by 7

HLA Associations of Intrathecal IgG Production against Specific Viruses in Multiple Sclerosis

Neidhart, S., Vlad, B., Hilty, M., Högelin, K. A., Ziegler, M., Berenjeno‐Correa, E., Reichen, I., Stridh, P., Jelčić, I., Khademi, M., et al. (2024) · Annals of Neurology · doi:10.1002/ana.26921 · Cited by 7

The emerging role of serum zinc in motor disability and radiological findings in patients with multiple sclerosis

Oraby, M. I., Hussein, M., Elkareem, R. M. A., & Elfar, E. (2019) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-019-0107-6 · Cited by 7

Role of a Novel Human Leukocyte Antigen-DQA1*01:02;DRB1*15:01 Mixed Isotype Heterodimer in the Pathogenesis of “Humanized” Multiple Sclerosis-like Disease

Kaushansky, N., Eisenstein, M., Boura‐Halfon, S., Hansen, B. E., Nielsen, C. H., Milo, R., Zeilig, G., Lassmann, H., Altmann, D. M., & Ben‐Nun, A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.641209 · Cited by 7

Oligoclonal band phenotypes in MS differ in their HLA class II association, while specific KIR ligands at HLA class I show association to MS in general

Gustavsen, M. W., Viken, M. K., Celius, E. G., Berge, T., Mero, I., Berg‐Hansen, P., Aarseth, J. H., Myhr, K., Søndergaard, H. B., Sellebjerg, F. T., et al. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.06.024 · Cited by 7

New Insights Into the Genetics of Autoimmune Myasthenia Gravis

Lisak, R. P., & Barcellos, L. F. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2014.4493 · Cited by 9

Effects of C2ta genetic polymorphisms on MHC class II expression and autoimmune diseases

Yau, A. C. Y., Piehl, F., Olsson, T., & Holmdahl, R. (2017) · Immunology · doi:10.1111/imm.12692 · Cited by 8

Autoimmune associated HLAs and T cell autoantigens exhibit common patterns across several autoimmune diseases

Saksager, A. B., Hede, F. D., & Barra, C. (2025) · Journal of Autoimmunity · doi:10.1016/j.jaut.2025.103443 · Cited by 6

Translational utility of experimental autoimmune encephalomyelitis: recent developments

Jagodic, M., Guerreiro‐Cacais, A. O., Lindahl, H., Flytzani, S., N’diaye, M., & Olsson, T. P. (2015) · Journal of Inflammation Research · doi:10.2147/jir.s76707 · Cited by 6

HLA Allele Frequencies in Pediatric and Adolescent Multiple Sclerosis Patients

Anagnostouli, M. C., & Gontika, M. P. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.81645 · Cited by 6

Multiple Sclerosis

Hauser, S. L., Oksenberg, J. R., & Baranzini, S. E. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-410529-4.00085-1 · Cited by 7

Unraveling susceptibility to multiple sclerosis

Briggs, F. B. S. (2019) · Science · doi:10.1126/science.aay1439 · Cited by 6

An accurate genetic colocalization method for the HLA locusPreprint

Butler‐Laporte, G., Lu, T., Morris, S., Zhang, W., Band, G., Hamilton, F., Chong, A. Y.-Y., Lin, K., Nanjala, R., Richards, J. B., et al. (2024) · medRxiv · doi:10.1101/2024.11.05.24316783 · Cited by 6

Natural language processing analysis of the theories of people with multiple sclerosis about causes of their disease

Haag, C., Steinemann, N., Ajdacic‐Gross, V., Schlomberg, J. T., Ineichen, B. V., Stanikić, M., Dressel, H., Daniore, P., Roth, P., Ammann, S., et al. (2024) · Communications Medicine · doi:10.1038/s43856-024-00546-3 · Cited by 5

Genetic Determinants of Multiple Sclerosis Susceptibility in People From Diverse Ancestral Backgrounds

Jacobs, B. M., Schalk, L., Tregaskis-Daniels, E., Scalfari, A., Nandoskar, A., Dunne, A., Gran, B., Mein, C. A., Sellers, C., Spilker, C., et al. (2026) · Neurology · doi:10.1212/wnl.0000000000214708 · Cited by 5

Current understanding of cardiovascular autonomic dysfunction in multiple sclerosis

Zahoor, I., Pan, G., Cerghet, M., ElBayoumi, T. A., Mao‐Draayer, Y., Giri, S., & Palaniyandi, S. S. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35753 · Cited by 6

Human Leukocyte Antigen (HLA)

Mahdi, B. M. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.73938 · Cited by 5

Comparison of recent updates in genetics, immunology, biomarkers, and neuroimaging of primary‐progressive and relapsing‐remitting multiple sclerosis and the role of ocrelizumab in the management of their refractory cases

Prajjwal, P., Marsool, M. D. M., Asharaf, S., Inban, P., Gadam, S., Yadav, R., Vora, N., Nandwana, V., Marsool, A. D. M., & Hussin, O. A. (2023) · Health Science Reports · doi:10.1002/hsr2.1422 · Cited by 6

Genetic and Environmental Susceptibility to Multiple Sclerosis

Goodin, D. S. (2021) · Medical Research Archives · doi:10.18103/mra.v9i6.2413 · Cited by 5

Cross-disorder analysis of schizophrenia and 19 immune diseases reveals genetic correlationPreprint

Pouget, J. G., Han, B., Wu, Y., Mignot, E. J.-M., Ollila, H. M., Barker, J., Spain, S., Dand, N., Trembath, R. C., Martin, J., et al. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/068684 · Cited by 5

The potential roles of nicotinic acetylcholine receptors in the pathogenesis of multiple sclerosis: A comprehensive review

Dastmalchi, N., & Hajiasgharzadeh, K. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.153906 · Cited by 4

No excess of autoimmune diseases in multiple sclerosis families from the Netherlands

Mescheriakova, J. Y., & Hintzen, R. Q. (2018) · Acta Neurologica Scandinavica · doi:10.1111/ane.12896 · Cited by 5

Altered Immune Phenotypes and HLA-DQB1 Gene Variation in Multiple Sclerosis Patients Failing Interferon β Treatment

Devi-Marulkar, P., Moraes-Cabé, C., Campagne, P., Corre, B., Meghraoui, A., Bondet, V., Llibre, A., Duffy, D., Maillart, É., Papeix, C., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.628375 · Cited by 4

A Major Histocompatibility Class I Locus Contributes to Multiple Sclerosis Susceptibility Independently from HLA-DRB1*15:01

Cree, B., Rioux, J. D., Mccauley, J. L., Gourraud, P., Mcelroy, J., Jager, P. L. D., Santaniello, A., Vyse, T. J., Gregersen, P. K., Mirel, D. B., et al. (2013)

A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis

Lincoln, M. R., Montpetit, A., Cader, M. Z., Saarela, J., Dyment, D. A., Tiislar, M., Ferretti, V., Tienari, P. J., Sadovnick, A. D., Peltonen, L., et al. (2005) · Nature Genetics · doi:10.1038/ng1647 · Cited by 326

HLA class I alleles tag HLA-DRB1 * 1501 haplotypes for differential risk in multiple sclerosis susceptibility

Chao, M. J., Barnardo, M., Lincoln, M. R., Ramagopalan, S. V., Herrera, B. M., Dyment, D. A., Montpetit, A., Sadovnick, A. D., Knight, J. C., & Ebers, G. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801042105 · Cited by 93

A second major histocompatibility complex susceptibility locus for multiple sclerosis

Yeo, T. W., Jager, P. L. D., Gregory, S. G., Barcellos, L. F., Walton, A., Goris, A., Fenoglio, C., Ban, M., Taylor, C. J., Goodman, R. S., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21063 · Cited by 175

A Second Major Histocompatibility Complex Susceptibility Locus for Multiple Sclerosis The International Multiple Sclerosis Genetics Consortium

(2016)